These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1073379)

  • 1. Relation of salivary amylase to Sjögren's syndrome.
    Greater Milw Dent Bull; 1975 Sep; 41(9):254. PubMed ID: 1073379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between postsialographical changes of salivary amylase levels in serum and the histopathological findings of sublingual glands in the patients with Sjögren's syndrome (author's transl)].
    Yamauchi K; Takaya M; Koriyama K; Ichikawa Y; Arimori S
    Ryumachi; 1981 Mar; 21(1):3-8. PubMed ID: 6169162
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic increase of amylase in primary sicca syndrome].
    Schmeck HJ; Viets CH
    Dtsch Med Wochenschr; 1984 Oct; 109(42):1604-6. PubMed ID: 6208003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum salivary isoamylases in Sjögren's Syndrome.
    Wolf RO; Ross ME; Tarpley TM
    Am J Clin Pathol; 1976 Jun; 65(6):1022-5. PubMed ID: 937245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum isoamylases in Sjögren's syndrome. Concentration levels and intra-individual variation.
    Magid E; Frost-Larsen K; Isager H; Manthorpe R; Prause JU
    Scand J Rheumatol; 1983; 12(2):129-32. PubMed ID: 6190225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary amylase and pancreatic enzymes in Sjögren's syndrome.
    Pal B; Griffiths ID; Katrak A; Junglee D; Dandona P
    Clin Chem; 1987 Feb; 33(2 Pt 1):305-7. PubMed ID: 2433075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More on enzymes in Sjögren's syndrome.
    Navarro S; Elena M; Coll J
    Clin Chem; 1988 Oct; 34(10):2179. PubMed ID: 2458868
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternate-day steroid therapy for patients with primary Sjögren's syndrome.
    Tabbara KF; Frayha RA
    Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome.
    Szántó A; Harangi M; Seres I; Paragh G; Zeher M
    Int Immunol; 2010 Jul; 22(7):605-9. PubMed ID: 20497955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
    Zipp MM; Yasbin L; al-Hashimi I
    Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The measurement of serum salivary isoamylase as a clinical parameter in Sjögren's syndrome.
    Kalk WW; Vissink A; Swaanenburg JC; Spijkervet FK; Roodenburg JL; Bootsma H; Kallenberg CG
    Rheumatology (Oxford); 2002 Jun; 41(6):706-8. PubMed ID: 12048305
    [No Abstract]   [Full Text] [Related]  

  • 12. [The accessory salivary glands in Sjögren's syndrome. Histological and ultrastructural study. Correlations with sialographic changes in the principal glands].
    Chomette G; Laudenbach P; Auriol M; Szpirglas H
    Rev Stomatol Chir Maxillofac; 1983; 84(3):121-7. PubMed ID: 6575430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary kallikrein in Sjögren's syndrome.
    Friberg B; Jonsson R; Linde A
    Clin Exp Rheumatol; 1988; 6(2):135-8. PubMed ID: 3180538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 9 in the saliva of patients with Sjögren's syndrome: comment on the article by Goicovich et al.
    Konttinen YT; Azuma M
    Arthritis Rheum; 2004 Jul; 50(7):2374; author reply 2375-6. PubMed ID: 15248240
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjogren's syndrome.
    Aziz KE; McCluskey PJ; Montanaro A; Wakefield D
    J Clin Lab Immunol; 1992 Jan; 37(1):39-49. PubMed ID: 1339235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal enzyme activities: new potential markers for Sjögren's syndrome.
    Sohar N; Sohar I; Hammer H
    Clin Biochem; 2005 Dec; 38(12):1120-6. PubMed ID: 16257401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysozyme concentration in tears of patients with sicca syndrome.
    Scharf J; Meshulam T; Obedeanu N; Nahir M; Zonis S; Merzbach D
    Ann Ophthalmol; 1982 Nov; 14(11):1063-4. PubMed ID: 7181337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase.
    Dawson LJ; Caulfield VL; Stanbury JB; Field AE; Christmas SE; Smith PM
    Rheumatology (Oxford); 2005 Apr; 44(4):449-55. PubMed ID: 15590764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
    Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of H-ATPase in distal nephron causing hypokalaemic distal RTA in a patient with Sjögren's syndrome.
    Bastani B; Haragsim L; Gluck S; Siamopoulos KC
    Nephrol Dial Transplant; 1995; 10(6):908-9. PubMed ID: 7566631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.